Abstract
creases in PEPFAR funding during the program’s early years helped create “a huge amount of enthusiasm for having 6 to 10 million on treatment by 2014 or 2013.” Now, she said, level funding and economic woes have blunted that enthusiasm. At the same time, however, Walensky credits PEPFAR with essentially creating a health care infrastructure in many developing countries and focusing global attention on the need for stronger health care systems in resource-limited regions. “How we prioritize what funds go into what places is going to be our global challenge for years to come.”
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
